MedPath

深圳海王药业有限公司

Ownership
-
Established
1989-12-12
Employees
-
Market Cap
-
Website
www.neptunus.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

85

NMPA:85

Drug Approvals

Docetaxel Injection

Product Name
多西他赛注射液
Approval Number
国药准字H20093755
Approval Date
May 14, 2024
NMPA

Oteracil Potassium

Product Name
奥替拉西钾
Approval Number
国药准字H20140016
Approval Date
Feb 2, 2024
NMPA

Gimeracil

Product Name
吉美嘧啶
Approval Number
国药准字H20140017
Approval Date
Feb 2, 2024
NMPA

Azithromycin Injection

Product Name
利普欣
Approval Number
国药准字H20010701
Approval Date
Oct 11, 2022
NMPA

Azithromycin Injection

Product Name
利普欣
Approval Number
国药准字H20030232
Approval Date
Oct 11, 2022
NMPA

Roxithromycin Granules

Product Name
罗红霉素颗粒
Approval Number
国药准字H20073899
Approval Date
Sep 13, 2022
NMPA

Azithromycin for Injection

Product Name
注射用阿奇霉素
Approval Number
国药准字H20064349
Approval Date
Sep 13, 2022
NMPA

Granisetron Hydrochloride Orally Disintegrating Tablets

Product Name
盐酸格拉司琼口崩片
Approval Number
国药准字H20070275
Approval Date
Sep 13, 2022
NMPA

Tinidazole Tablets

Product Name
替硝唑片
Approval Number
国药准字H20073865
Approval Date
Sep 13, 2022
NMPA

Amoxicillin and clavulanate Potassium for Suspension

Product Name
阿莫西林克拉维酸钾(4:1)干混悬剂
Approval Number
国药准字H20000322
Approval Date
Mar 9, 2022
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 9
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.